文献速递传染病防控与疫情报告免疫规划

美国紧急H5疫苗接种对2.3.4.4分支H5N2高致病性禽流感病毒攻击的白来航鸡的保护作用

Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
PubMed 文献 · Vaccine · 2017-05-26

2014年12月至2015年6月美国暴发2.3.4.4分支H5Nx高致病性禽流感疫情。评估三种疫苗单独或联合对白来航鸡抵抗2.3.4.4分支H5N2高致病性禽流感病毒攻击的效果:rHVT-H5单剂或联合rgH5N1/RP-H5初免-加强、rgH5N1或RP-H5单剂、rgH5N1双剂均提供临床保护并显著减少排毒,双剂rgH5N1在加强后20周攻击仍具持久保护。

要点

  • rHVT-H5单剂或联合rgH5N1/RP-H5初免-加强策略提供高水平保护性免疫并显著减少排毒。
  • rgH5N1或RP-H5单剂接种为成年鸡提供临床保护并显著减少排毒。
  • rgH5N1双剂接种在加强后20周攻击时保护成年鸡免于临床症状和死亡,具持久免疫并显著减少排毒。

核心结论

  • 这些研究支持使用遗传相关的疫苗,可能与广谱保护性初免疫苗联合,用于年轻和成年蛋鸡针对2.3.4.4分支H5Nx高致病性禽流感病毒的紧急疫苗接种计划。

研究设计与样本

  • 研究评估三种疫苗单独或联合在白来航鸡中对2.3.4.4分支H5N2高致病性禽流感病毒攻击的功效。
  • 三种疫苗为:含2.3.4.4分支血凝素基因的灭活反向遗传H5N1疫苗(rgH5N1)和RNA颗粒疫苗(RP-H5),以及含2.2分支血凝素基因的重组火鸡疱疹病毒载体疫苗(rHVT-H5)。
  • 研究分为三个部分:研究1评估单剂rHVT-H5和初免-加强(rHVT-H5+rgH5N1或rHVT-H5+RP-H5);研究2评估rgH5N1或RP-H5单剂;研究3评估rgH5N1双剂在加强后20周攻击。

主要发现

  • 研究1中,单剂rHVT-H5和初免-加强策略(rHVT-H5+rgH5N1或rHVT-H5+RP-H5)提供高水平保护性免疫并显著减少病毒排毒。
  • 研究2中,rgH5N1或RP-H5单剂接种为成年鸡提供临床保护并显著减少病毒排毒。
  • 研究3中,rgH5N1双剂接种在加强后20周攻击时保护成年鸡免于临床症状和死亡,具高水平持久保护性免疫并显著减少病毒排毒。

临床怎么用

  • 作者认为这些研究支持使用遗传相关疫苗,可能与广谱保护性初免疫苗联合,用于针对2.3.4.4分支H5Nx高致病性禽流感病毒的紧急疫苗接种计划,适用于年轻和成年蛋鸡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

During December 2014-June 2015, the U.S. experienced a high pathogenicity avian influenza (HPAI) outbreak caused by clade 2.3.4.4 H5Nx Goose/Guangdong lineage viruses with devastating consequences for the poultry industry. Three vaccines, developed based on updating existing registered vaccines or currently licensed technologies, were evaluated for possible use: an inactivated reverse genetics H5N1 vaccine (rgH5N1) and an RNA particle vaccine (RP-H5), both containing the hemagglutinin gene of clade 2.3.4.4 strain, and a recombinant herpesvirus turkey vectored vaccine (rHVT-H5) containing the hemagglutinin gene of clade 2.2 strain. The efficacy of the three vaccines, alone or in combination, was assessed in White Leghorn chickens against clade 2.3.4.4 H5N2 HPAI virus challenge. In Study 1, single (rHVT-H5) and prime-boost (rHVT-H5+rgH5N1 or rHVT-H5+RP-H5) vaccination strategies protected chickens with high levels of protective immunity and significantly reduced virus shedding. In Study 2, single vaccination with either rgH5N1 or RP-H5 vaccines provided clinical protection in adult chickens and significantly reduced virus shedding. In Study 3, double rgH5N1 vaccination protected adult chickens from clinical signs and mortality when challenged 20weeks post-boost, with high levels of long-lasting protective immunity and significantly reduced virus shedding. These studies support the use of genetically related vaccines, possibly in combination with a broad protective priming vaccine, for emergency vaccination programs against clade 2.3.4.4 H5Nx HPAI virus in young and adult layer chickens.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bertran K, Balzli C, Lee DH, et al. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus. Vaccine. 2017. PMID: 28554502. doi:10.1016/j.vaccine.2017.05.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。